A Study of LY2801653 in Healthy Participants Who Are Not Able to Have Children
NCT02370485
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
LY2801653
Sponsor
Eli Lilly and Company